Neudle.com: betaseron

Neurology Specific Literature Search

Differential
(Click to cross reference)

abortion, spontaneous

acetylcholine receptor antibody

acute necrotizing encephalitis

advances in neurology

adverse drug reaction

Aicardi-Goutieres syndrome

altered states of consciousness

anesthesia, epidural

anesthesia, spinal

antiarrhythmic drugs

antibiotics, neurologic complications with

anticholinergic drugs

anticholinergic drugs, side effects of

anticonvulsants

anticonvulsants, untoward effects of

antiviral agents

aorta, sheathing

arrhythmia, cardiac

autoimmune disease

axonal degeneration

B cell lymphocytes

Barkhof MR criteria for MS

basal ganglia, calcification of

behavioral disorder

beta adrenergic blocker

bladder dysfunction

blood brain barrier

brachial neuritis

BRAF protooncogene

brainstem, lesion of

calcification, intracranial

calcium antagonist

carcinoma of breast

carcinoma of lung

CAT scan, abdomen

CAT scan, abnormal

CAT scan, chest

cataracts, congenital

central nervous system, infection of

cerebellar lesion

cerebral cortical atrophy

cerebrospinal fluid, abnormal

cerebrospinal fluid, cytology

cerebrospinal fluid, elevated protein of

cerebrospinal fluid, gammaglobulin of

cerebrospinal fluid, oligoclonal IgG in

cerebrospinal fluid, xanthochromia of

chilbran skin lesions

chorioretinitis

Churg-Strauss syndrome

Clinical Pathologic Conference(C.P.C.)

cold intolerance

conduction block

contrast agents, neurotoxicity of

controversies in neurology

cortical blindness

cost effectiveness

cotton-wool spots

cryoglobulinemia

cyclophosphamide

cyst, parenchymal

cyst, porencephalic

cytomegalic inclusion disease

cytosine arabinoside

dementia, treatment of

dentate nuclei, lesion of

depression, psychotic

developmental milestones, loss of

diabetes insipidus

diagnostic criteria

differential diagnosis

disability rating scale, neurological

disability, neurological

drug induced neurologic disorders

dystonia, children

electrocardiogram, abnormal

electroencephalogram

electroencephalogram, abnormalities of

electron microscopy

emotional lability

encephalitis, brainstem

encephalitis, viral

encephalitis, viral-causes of

Erdheim-Chester disease

evidence-based research

eye movement, disorders of

facial nerve palsy

facial weakness

feeding disorder

flu-like illness

fluoroquinolones

fundus, abnormality of

gammaglobulin therapy, intravenous

genetic diagnosis, prenatal

genetic neurologic disorders

glioblastoma multiforme(astrocytoma Gr.III)

Guillain Barre syndrome

headache, frontal

hepatic failure

hepatitis C virus

herpes labialis

herpes simplex encephalitis

herpes simplex encephalitis, differential diagnosis of

herpes simplex encephalitis, recurrent

herpes simplex encephalitis, treatment of

herpes simplex myelitis

herpes simplex virus

herpes simplex virus infection, immunosuppressed patient

herpes simplex virus, human nervous system and

herpes simplex virus, localization of

herpes simplex virus, malignancy with

herpes simplex virus, pathogenesis of

herpes simplex virus, pathology of

herpes simplex, neurocutaneous lesions in

herpes virus infection

herpes zoster, disseminated

herpes, genital

human herpesvirus 6

human T-lymphotropic virus type I(HTLV-I)

hydrocephalus, exvacuo

hyperpyrexia, CNS disorder causing

hypoglycorrhachia

hypothalamus, damage to

iatrogenic neurologic disorders

idiopathic thrombocytopenic purpura

immunofluorescent exam of CSF cells

immunomodulation

immunosuppression

immunosuppressive agents

inclusion bodies, intranuclear

infectious mononucleosis

intellectual deficit

interferon alpha

interferon antibodies

interferon beta 1-a

interferon beta 1-b

interferon gamma

interferon inducer

interferon, intrathecal

interferon, intraventricular

intracranial pressure, increased

intrauterine infection, viral

intrauterine infection, viral of CNS

iododeoxyuridine

Jakob-Creutzfeldt disease

leukoencephalopathy

level of consciousness, decreased

limbic encephalitis

liver function enzymes

long bone lesion

low birth weight

malformation, CNS, congenital

meningitis, aseptic

menses, irregular

mental status, abnormal

monoamines, brain

monoclonal antibodies

mononeuropathy multiplex

movement disorder

MRI, black holes on

MRI, contrast enhanced

MRI, demyelinating disease

MRI, hypointense signal foci on

MRI, lesion burden

MRI, skull bone changes

multiple sclerosis

multiple sclerosis, benign form of

multiple sclerosis, children

multiple sclerosis, chronic progressive

multiple sclerosis, clinical patterns

multiple sclerosis, conversion to clinically definite

multiple sclerosis, cost of

multiple sclerosis, diagnosis of

multiple sclerosis, diagnostic criteria

multiple sclerosis, disability status scale

multiple sclerosis, early onset

multiple sclerosis, monosymptomatic

multiple sclerosis, pathogenesis

multiple sclerosis, prognosis

multiple sclerosis, relapsing

multiple sclerosis, secondary progressive

multiple sclerosis, treatment of

multiple sclerosis, treatment of, first attack

multiple sclerosis, worsening

myasthenia gravis

myasthenia gravis, drug induced

myasthenia gravis, unmasked

myasthenic syndrome

neoplasm, primary intracerebral

neurofibrillary degeneration

neurologic complications of, surgery

neurologic disease

neurologic disease, diagnoses of

neuromuscular blockade

neuropathy, cryoglobulinemic

neuropathy, medication induced

neuropathy, sensory

neuropathy, vasculitic, nonsystemic

neutralizing antibodies

neutralizing antibodies, cross-reactive

nonsteroidal anti-inflammatory drug

Ommaya reservoir

opportunistic infection

optic neuritis, treatment of

optic neuropathy

patient information and support

personality change

pituitary stalk

pituitary stalk, lesion of

pituitary, lesion of

pleocytosis of cerebrospinal fluid

polyinosinic cytidic acid(poly IC)

polymerase chain reaction

pons, lesion of

practice guidelines

pregnancy, neurologic complications in

prevention of neurologic disorders

progressive multifocal leucoencephalopathy

psychiatric problems in neurologic disorders

psychomotor retardation

pyramidal tract dysfunction

quality of life

radiation therapy, total body

remote effect of cancer on the nervous system

retroperitoneal fibrosis

risk-benefit assessment

sclerosis, bone

seizure, drug-induced

seizure, intractable

seizure, psychomotor-temporal lobe

serologic testing

serologic testing of cerebrospinal fluid

serum alanine aminotransferase

serum glutamic oxaloacetic transaminase

skin, lesions in neurologic disorders

spastic diplegia

speech disorder, childhood

startle reaction

status epilepticus

steroid therapy, CNS treatment and complications with

subacute myelo-opticoneuropathy(S.M.O.N.)complex

subacute sclerosing panencephalitis(S.S.P.E.)Dawson's disease

subacute sclerosing panencephalitis, adult onset

subtemporal decompression

suprasellar lesion

T cell lymphocytes

tetrahydroaminoacridine

thrombocytopenia

transplacental virus infections

treatment of neurologic disorder

trigeminal neuralgia

trigeminal neuralgia, surgical treatment of

tumor necrosis factor

tumor necrosis factor inhibitor

urinary tract infection

ventricular enlargement

viral infection

viral infection, CNS

viral infection, reactivation

white matter disease

Showing articles 100 to 150 of 155 << Previous Next >>

Randomised Double-Blind Placebo-Controlled Study of Interferon B-1a in Relapsing/Remitting Multiple Sclerosis
Lancet 352:1498-1504,1486, PRISMS, 1998

Placebo-Controlled Multicentre Randomised Trial of Interferon B-1b in Treatment of Secondary Progressive Multiple Sclerosis
Lancet 352:1491-1497,1486, European Study Group on Interferon B-1b in Seconda, 1998

Current Immunotherapy in Multiple Sclerosis
Immunology and Cell Biology 76:55-64, Bashir,K.&Whitaker,J.N., 1998

Long-Term Follow-up of Pts with SSPE Treated with Intraventricular alpha-Interferon
Neurol 48:526-528, Anlar,B.,et al, 1997

Drugs and Myasthenia Gravis, An Update
Arch Int Med 157:399-408, Wittbrodt,E.T., 1997

Interferon Beta Results in Immediate Reduction of Contrast-Enhanced MRI Lesions in MS Pts Followed by Weekly MRI
Neurol 48:1446-1448, Calabresi,P.A.,et al, 1997

Character of MRI Response to Trtm with Interferon Beta-1B:Enhancing MRI Lesion Freq as Prim Outcome Measure
Neurol 49:862-869, Stone,L.A.,et al, 1997

Impact of Interferon Beta-1A On Neurologic Disability in Relapsing Multiple Sclerosis
Neurol 49:358-363, Rudick,R.A.,et al, 1997

Anticytokine Antibodies in Beta Interferon-Trated MS Patients and the Need for Testing
Neurol 49:647-650, Pachner,A.R., 1997

The Quality-of-Life Effects of Interferon Beta-1b in MS
Arch Neurol 54:1475-1480, Schwartz,C.E.,et al, 1997

Management of Multiple Sclerosis
NEJM 337:1604-1611, Rudick,R.A.,et al, 1997

Management of Patients Receiving Interferon Beta-1b for MS:Report of a Consensus Conf
Neurol 46:12-18, Lublin,F.D.,et al, 1996

Side Effect Profile of Interferon Beta-1b in MS:Results of an Open Label Trial
Neurol 46:552-554, Neilley,L.K.,et al, 1996

Interferon-Alpha is Effective in HTLV-I-Associated Myelopathy:A Multicenter, Randomized, Double-Blind, Controlled Trial
Neurol 46:1016-1021, Izumo,S.,et al, 1996

Progressive Multifocal Leukoencephalopathy:Clinical and MR Response to Treatment
AJNR 17:597-600, Garrels,K.,et al, 1996

Neutralizing Antibodies During Treatment of Multiple Sclerosis with Interferon Beta-1b
IFNB MS Study Group & UBC MS. MRI Analysis Group, Neurol 47:889-8946., , 1996

Guidelines for Physicians with Patients on IFNB-1b:The Use of an Assay for Neutralizing Antibodies (NAB)
Neurol 47:865-866, Paty,D.,et al, 1996

Nonsystemic Vasculitic Mononeuropathy Multiplex, Cryoglobulinemia, and Hepatitis C
Muscle & Nerve 19:1596-1602996., David,W.S.,et al, 1996

Interferon Beta in Multiple Sclerosis
BMJ 313:1159, 1157, 1195996., Richards,R.G., 1996

The Interferons:Biological Effects, Mechanisms of Action, and Use in Multiple Sclerosis
Ann Neurol 37:7-15, Weinstock-Guttman,B.,et al, 1995

New Treatments for Multiple Sclerosis
BMJ 310:345-346, McDonald,W.I., 1995

Hepatitis C Infection, Cryoglobulinemia, and Vasculitic Neuropathy. Treatment with Interferon Alfa:Case Rpt & Literat Review
Neurol 45:407-411, Khella,S.L.,et al, 1995

The Impact of New Pharmaceutical Agents on the Cost of Neurologic Care
Neurol 45:569-572, Gunderson,C.H., 1995

Myasthenia Gravis During Interferon Alfa Therapy
Neurol 45:382-383, Batocchi,A.P.,et al, 1995

Interferon Beta-1b in the Trtm of MS:Outcome of the Randomized Controlled Trial
IFNB Study Gr, Neurol 45:1277-12851995., , 1995

Effect of Interferon-B on Blood-Brain Barrier Disrupt Demonst by Contrast MRI in Relapsing-Remitting MS
Ann Neurol 37:611-619, Stone,L.A.,et al, 1995

Copolymer 1 Reduces Relapse Rate & Improves Disability in Relapsing-Remitting MS:Multictr Trial
Neurol 45:1268-1276, Johnson,K.P.,et al, 1995

Severe Necrotizing Cutaneous Lesions Complicating Treatment with Interferon Beta-1b
NEJM 332:1584, Sheremata,W.A.,et al, 1995

Betaseron for Multiple Sclerosis:Implications for Therapeutics
Arch Neurol 51:125-128, Rudick,R., 1994

Chronic Systemic High-Dose Recombinant Interferon Alfa-2a Reduces Exacerbation Rate & MRI Signs in MS
Neurol 44:406-413, Durelli,L.,et al, 1994

Interferon-Associated Refractory Status Epilepticus
pediatrics 93:511-512, Miller,V.S.,et al, 1994

Practice Advisory on Selection of Patients with Multiple Sclerosis for Treatment with Betaseron
Neurol 44:1537-1540, Alter,M.,et al, 1994

Are Magnetic Resonance Findings Pred of Clinical Outcome in Therapeutic Trials in MS? The Dilemma of Interferon-B
Ann Neurol 36:14-18, McDonald,W.I.,et al, 1994

Sudden Hearing Loss Associated with Interferon
Lancet 343:1134-1135, Kanda,Y.,et al, 1994

A Brief History of the Use of Interferons as Treatment of Multiple Sclerosis
Arch Neurol 51:1245-1252, Jacobs,L.&Johnson,K.P., 1994

Interferon Beta-1b is Effective in Relapsing-Remitting MS
Clinical Results of a Placebo-Controlled Trial, IFNB MS Study Grp, Neurol 43:655-661, 64193., , 1993

Interferon Beta-1b is Effective in Relapsing Remitting MS, MRI Analysis Results of Placebo-Control Trial
Neurol 43:662-667, 6411993., Paty,D.W.,et al, 1993

Successful Outcome of Progressive Multifocal Leukoencephalopathy with Cytarabine and Interferon
Ann Neurol 33:407-411, Steiger,M.J.,et al, 1993

Intraventricular Interferon and Oral Inosiplex in the Treatment of Subacute Sclerosing Panencephalitis
Neurol 42:488-491, Yalaz,K.,et al, 1992

Immunotherapy of Multiple Sclerosis
Ann Neurol 23:211-223, Weiner,H.L.&Hafler,D.A., 1988

Bilateral Neuralgic Amyotrophy Induced by Interferon Treatment
Arch Neurol 45:449-451, Bernsen,P.L.J.A.,et al, 1988

Intrathecally Administered Natural Human Fibroblast Interferon Reduces Exacerbations of Multiple Sclerosis
Arch Neurol 44:589-595, Jacobs,L.,et al, 1987

From the National SSPE Registry
Neurol 37:1883-1884, Dyken,P.R.&Cunningham,S., 1987

Systemic a-Interferon in Multiple Sclerosis, Long-Term Patient Follow-Up
Arch Neurol 44:61-63, Panitch,H.S., 1987

Multicentre Double-Blind Study of Intrathecally Admin Natural Human Fibroblast Interferon on Exacerb of MS
Lancet 2:1411-1413, Jacobs,L.,et al, 1986

A Major Role for Viruses in Acute Childhood Encephalopathy
Lancet 1:989-991, Kennedy,C.R.,et al, 1986

Use of Interferon in Multiple Sclerosis
Ann Neurol 18:432-433, McFarlin,D.E., 1985

Intrathecal Interferon in the Treatment of Multiple Sclerosis, Patient Follow-Up
Arch Neurol 42:841-847, Jacobs,L.,et al, 1985

Neurological Effects of Recombinant Human Interferon
BMJ 286:262-264, Smedley,H.,et al, 1983

Intrathecal Interferon in Multiple Sclerosis
Arch Neurol 39:609-615, Jacobs,L.,et al, 1982

Showing articles 100 to 150 of 155 << Previous Next >>